TECHNICAL GUIDES

Specifications translated into usable requirements.

Engineering guidance on compatibility, components, materials, performance, packaging, sterilization and acceptance checks.

VEMERIX technical guide cover illustrating the buyer audit workflow for a medical device supplier's design and development file under FDA QMSR 21 CFR Part 820, ISO 13485 Clause 7.3, CP 7382.850, EN ISO 13485, and GB/T 42061-2022.
How to Review a Supplier's Design and Development File After QMSRAn incoming audit guide for medical device distributors, OEMs, and private-label partners: why 21 CFR 820.30 is reserved under QMSR, how ISO 13485:2016 Clause 7.3 carries the legal duties, what CP 7382.850 inspects under Design and Development, how EN ISO 13485 and GB/T 42061-2022 overlay the file, the DHF-to-medical-device-file pivot, and an 8-point buyer acceptance protocol.September 15, 2026 · 16 min read
ISO 11607 packaging declaration of conformity recognition in 2026: ISO 11607-1/2:2019 including Amendment 1:2023, US FDA Rec 14-594 and 14-595 versus Rec 14-530 and 14-531, EU Decision 2024/815, and China GB/T 19633.1-2024
Which ISO 11607 Packaging Declaration of Conformity Survives 20 December 2026: Why FDA Rec 14-594 and 14-595 Name 2019 Including AMD1:2023, Why Rec 14-530 and 14-531 Remain Acceptable Until That Date, Why Decision (EU) 2024/815 Already Cites EN ISO 11607-1:2020/A1:2023, and Why GB/T 19633.1-2024 Is the 2019 IDT Implemented 1 December 2025An operational technical and regulatory guide for international medical-device distributors, OEM buyers, and quality engineers evaluating sterile-barrier packaging validation files, declarations of conformity, and recognition timelines across the US, EU, and China in September 2026.September 10, 2026 · 17 min read
Which ISO 10993-7 edition governs an EO residual CoA in 2026: ISO 10993-7:2026 third edition publication versus US FDA Recognition Number 2-275, EU MDCG 2024-13, and China GB/T 16886.7-2015
Which ISO 10993-7 Edition Governs an EO Residual CoA in 2026: Why ISO 10993-7:2026 Is Not FDA Recognition 2-275, Why the 25 May 2026 Part 1 Update Did Not Move Part 7, and Why MDCG 2024-13 Still Names EN ISO 10993-7:2008+A1:2022An operational technical and regulatory guide for international medical-device distributors, OEM buyers, and quality engineers evaluating EO-sterilized single-use device residual certificates of analysis, dissipation curves, and regulatory recognition across the US, EU, and China in 2026.September 9, 2026 · 16 min read
ISO 15223-1 EC REP vs EU REP medical device label acceptance guide illustrating the 2026 transition framework, Implementing Decisions 2026/1231 and 2026/1313 withdrawal dates, MDCG 2021-5 Rev. 1 Appendix rules, and FDA recognition numbers 5-148 and 5-134
When EC REP Is Still Acceptable on a Medical Device Label After 17 June 2026: ISO 15223-1:2021/Amd 1:2025 XX REP and EU REP, Commission Implementing Decisions (EU) 2026/1231 and 2026/1313, MDCG 2021-5 Rev. 1 Appendix, FDA Recognition 5-148 versus 5-134, 21 CFR 801.15, and Why a Notified Body Does Not Have to Pre-Approve the Editorial ChangeAn operational technical and regulatory guide for international medical-device distributors, OEM buyers, and quality teams evaluating CE-marked sterile single-use devices under ISO 15223-1 clause 5.1.2, EU MDR/IVDR harmonised-standard withdrawal dates, and US FDA consensus-recognition clocks.September 6, 2026 · 16 min read
Technical-guide cover for reviewing a supplier production and process-control file under FDA QMSR after 2 February 2026
How to Review a Supplier's Production and Process-Control File After QMSR: Why 21 CFR 820.70, 820.75 and 820.80 Are Reserved, What ISO 13485 Clause 7.5 and 21 CFR 820.45 Require, What Compliance Program 7382.850 Inspects under Production and Service Provision, and Why a DHR Binder or Contract-Sterilizer Listing Is Not the FileA field-by-field file-review guide for medical device distributors, OEM buyers, and hospital procurement teams evaluating sterile single-use suppliers after 2 February 2026: why 21 CFR 820.70, 820.75, and 820.80 are reserved, what ISO 13485 Clause 7.5 and 21 CFR 820.45 mandate for production, process validation, and labeling inspection, and how FDA Compliance Program 7382.850 audits Production and Service Provision.September 4, 2026 · 16 min read
VEMERIX technical guide cover illustrating the 7-point buyer audit workflow for medical device complaint handling and CAPA under FDA QMSR 21 CFR Part 820, ISO 13485 Clauses 8.2.2, 8.3, 8.5.2, 8.5.3, 21 CFR 820.35, and CP 7382.850.
How to Review a Supplier's CAPA and Complaint File After QMSR: Why 21 CFR 820.100 and 820.198 Are Reserved, What ISO 13485 Clauses 8.2.2 / 8.3 / 8.5.2 / 8.5.3 and 21 CFR 820.35 Require, What Compliance Program 7382.850 Inspects, and Why an MDR Report Is Not the Complaint FileAn incoming audit guide for medical device distributors, OEMs, and hospital procurement teams: why 21 CFR 820.100 and 820.198 are reserved under QMSR, how ISO 13485 Clauses 8.2.2, 8.3, 8.5.2, and 8.5.3 carry the legal duties, what 21 CFR 820.35 adds on top, what CP 7382.850 inspects under Measurement, Analysis, and Improvement, why an MDR report is not the complaint file, and a 7-point buyer acceptance protocol.September 2, 2026 · 18 min read
VEMERIX technical guide cover illustrating the 7-point buyer audit workflow for medical device purchasing controls, outsourced sterilization, QMSR 21 CFR Part 820 compliance under ISO 13485 Clauses 4.1.5 and 7.4, and CP 7382.850 inspection gates.
How to Review a Supplier's Purchasing Controls and Outsourcing File After QMSR: Why 21 CFR 820.50 Is Reserved, What ISO 13485 Clauses 4.1.5 and 7.4 Require, What Compliance Program 7382.850 Inspects, and a Buyer Acceptance ChecklistA practical buyer's audit guide for medical device purchasing and outsourcing files: why 21 CFR 820.50 is reserved under QMSR, how ISO 13485 Clauses 4.1.5 and 7.4 carry the legal duties, what FDA Compliance Program 7382.850 inspects, why supplier-audit reports are no longer exempt, and a 7-point incoming acceptance checklist.August 31, 2026 · 19 min read
VEMERIX technical guide cover illustrating the 7-step buyer audit workflow for medical device ISO 14971 risk management files, QMSR requirements, EN ISO 14971:2019+A11:2021 for MDR, GB/T 42062-2022, and supplier acceptance checks.
How to Review a Supplier's ISO 14971 Risk Management File: What QMSR Actually Requires After 2 February 2026, EN ISO 14971:2019+A11:2021 for MDR, China's GB/T 42062-2022, and a Buyer Acceptance ChecklistA practical buyer's audit guide for medical device risk management files: separating ISO 13485 QMSR process mandates from ISO 14971 conformity, verifying EN ISO 14971:2019+A11:2021 for EU MDR, navigating China's GB/T 42062-2022, and executing a 7-point incoming acceptance protocol.August 27, 2026 · 18 min read
VEMERIX technical guide cover showing sterile hypodermic needle specification and incoming acceptance workflow: ISO 7864 dimensions, ISO 9626 tubing, ISO 6009 colour coding, ISO 80369-7 Luer fit, FDA product code FMI 510(k) verification, and China Class III NMPA evidence pack.
Sterile Hypodermic Needle Specification and Incoming Acceptance: ISO 7864 Dimensions, ISO 9626 Tubing, ISO 6009 Colour Coding, Luer Fit, and the FDA FMI / China Class III Evidence PackA specification and lot-acceptance guide for sterile single-use hypodermic needles: mapping ISO 7864, ISO 9626 tubing, ISO 6009 colour coding, ISO 80369-7 Luer fit, FDA product code FMI 510(k) evidence, China Class III registration requirements, and the GB 15811-2025 transition timeline.August 24, 2026 · 19 min read
VEMERIX technical guide cover showing the step-by-step review workflow for medical device ISO 10993 biological evaluation files, contact endpoints, the 2025 edition transition to 2029, and US/EU/China acceptance checks.
How to Review a Supplier's ISO 10993 Biocompatibility File: Endpoints by Contact and Duration, the 2025 Edition Transition (FDA Deadline July 2029), and a US/EU/China Acceptance ChecklistA practical buyer's audit guide for medical device biological safety files: matching endpoints to contact category and duration, verifying test-article final form, navigating the ISO 10993-1:2025 transition across FDA, EU MDR and China NMPA, and spotting disqualifying file gaps.August 22, 2026 · 18 min read
Component mechanics, sterile kit components, and lot-acceptance testing framework for disposable circumcision anastomat and stapler devices.
Disposable Circumcision Anastomat and Stapler: Device Mechanics, Sterile-Kit Components and Lot-Acceptance Tests for Procurement and Biomedical EngineeringA component-level technical guide to the single-use circumcision anastomat and stapler: the bell-and-staple firing mechanism, what belongs in the sterile convenience kit, the staple-formation and sterile-barrier lot-acceptance tests, and the US, EU and China classification — including why no US 510(k) predicate and no WHO prequalification exist for the stapler.August 9, 2026 · 18 min read
VEMERIX technical guide cover showing an ISO 11137 radiation sterilization validation framework, VDmax decision table, and modality comparison.
Radiation (Gamma, Electron-Beam and X-Ray) Sterilization Validation for Single-Use Medical Devices: An ISO 11137, VDmax and FDA Evidence Guide for OEM and Private-Label BuyersQualifying a radiation-sterilized single-use device OEM requires verifying an ISO 11137 validation protocol, substantiating the 25 kGy or 15 kGy sterilization dose via VDmax, selecting the optimal modality (gamma vs e-beam vs X-ray), capping polymer maximum doses, and aligning with the 4-month dose-audit interval under ISO 11137-1:2025 and the FDA Radiation Master File Pilot.August 4, 2026 · 18 min read
VEMERIX technical guide cover showing an ISO 11135 EO sterilization validation acceptance framework and ISO 10993-7 residual limits.
Ethylene Oxide Sterilization Validation for Single-Use Medical Devices: An ISO 11135 Process, ISO 10993-7 Residual and FDA Evidence Guide for OEM and Private-Label BuyersQualifying a sterile single-use device OEM demands a validated ISO 11135 process, documented ISO 10993-7 residual dissipation profiles below 4 mg EO / 9 mg ECH for limited contact, clear parametric or BI release protocols, and a regulatory change-control strategy under the FDA Sterilization Master File pilots.August 3, 2026 · 16 min read